General

Dupuytren Awareness

Promoting Dupuytren awareness is a cornerstone of making progress toward a Dupuytren cure. The Dupuytren Research Group has been promoting Dupuytren awareness to patients and physicians for the last 10 years through social media, online videos, academic journal articles and textbooks, scientific conferences, and public awareness seminars. We’ve had limited television exposure because our financial […]

Read more ›
The Need for Nonprofit Medical Research
On: Aug 16, 2019
By: Charles Eaton

Why isn’t there a drug for Dupuytren already? You might hear that surgeons don’t want a Dupuytren cure because it’s so profitable – but take it from a hand surgeon: if Dupuytren disappeared today, surgeons would be happier than patients: no one will miss Dupuytren. So why isn’t there a drug to slow down or […]

Read more ›
DRG goes to Washington
On: Jul 21, 2019
By: Charles Eaton

On July 10th and 11th, the Dupuytren Research Group went to Washington DC. We visited offices of Congressional representatives and other organizations to raise awareness about the impact of Dupuytren disease and the need for federal funding of Dupuytren research. Right now, there are no federal funds directed specifically for Dupuytren research – not at […]

Read more ›
Dupuytren and Rare Disease Research
On: Jul 1, 2019
By: Charles Eaton

Is Dupuytren disease common or rare? I recently attended the Rare Drug Development Symposium in Philadelphia. Why? Is Dupuytren really a rare disease? Yes and no. Mild Dupuytren is common but very severe Dupuytren is rare – in the same way that cats are common but chimeric cats with crazy colors are rare. What does […]

Read more ›
Ten Things to Know About Dupuytren
On: Mar 26, 2019
By: Charles Eaton

There are many reasons to know about Dupuytren disease. Ten of them are on your hands. When Healthgrades.com wanted to know more about Dupuytren disease, they reached out to the Dupuytren Research Group. See the Healthgrades Dupuytren review Dupuytren’s Contracture: 10 Things Doctors Want You to Know featuring Dupuytren specialists on the Dupuytren Research Group […]

Read more ›
Dupuytren research is rare disease research
On: Feb 28, 2019
By: Charles Eaton

Happy Rare Disease Day! Did you know that according to the US Government, Dupuytren is a rare disease? If you count everyone with any degree of Dupuytren disease, it’s fairly common. In the US alone, the number of Dupuytren sufferers projects to about 10 million people. But, if you ask the FDA, Dupuytren disease is a […]

Read more ›
Shine a light on Dupuytren?
On: Jan 24, 2019
By: Charles Eaton

Dupuytren biology has a lot of overlap with wound healing biology. One description of Dupuytren is that it’s like the body is trying to heal a wound that isn’t there. I used to worry that any treatment described as “promoting” or “accelerating” wound healing might be exactly the wrong thing to do for Dupuytren or […]

Read more ›
Dupuytren: restoring balance vs. winning the war
On: Jan 10, 2019
By: Charles Eaton

There were a number of responses to the last blog post. Annie Stratton wrote something so insightful I’ve included it with permission at the end of this post. The last post used the analogy of war, the war on Dupuytren. That seemed reasonable for several reasons – the importance of strategy and tactics, the concept of […]

Read more ›
Strategies and Tactics of Dupuytren Treatment: Measurement
On: Jan 8, 2019
By: Charles Eaton

This is the introduction to an upcoming series of discussions on the science behind new potential preventive Dupuytren treatments. The guiding mission of the Dupuytren Research Group is to do what needs to be done to prevent and stop Dupuytren. Our goal is the conquest of Dupuytren. Dupuytren damages hands, but the main effort of the […]

Read more ›